| Heading: |
Drugs: Labelling |
| Question ID: |
1746231 |
| UIN: |
17453 |
| House: |
Commons |
| Date tabled: |
2024-12-02 |
| Asking Member ID: |
5326 |
| Asking Member display name: |
Edward Morello
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Edward Morello
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, if his Department will make an assessment of the potential merits of bringing forward legislative proposals on requiring drugs manufacturers to include additional labelling on the front of boxes of |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2024-12-10 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The legislative requirements for the labelling of medicines are set out in Schedules 24 and 25 of the Human Medicines Regulations 2012. The regulations are continually under review and updated as and when a need is identified. It should be noted that the ... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |